A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples

Giuseppe Pelosi, Flavia Melotti, Alberto Cavazza, Giulio Rossi, Patrick Maisonneuve, Paolo Graziano, Mattia Barbareschi, Yukio Nakatani, Mauro Papotti

Research output: Contribution to journalArticle

Abstract

Background: As pulmonary sarcomatoid carcinomas (PSCs) are life-threatening tumors, an improvement in their recognition in small-sized tumor samples is clinically warranted. Materials and Methods: Preoperative biopsy samples and paired surgical specimens from 20 pleomorphic carcinomas, two pulmonary blastemas and one carcinosarcoma (training set) were studied for vimentin immunohistochemistry. A modified vimentin histologic score (M-VHS) was devised by multiplying three independently assessed parameters, i.e. the percentage of positive cells (from 0 to 5+, by quintiles), the intensity of immunostaining (low=1 vs. strong=2) and the distribution pattern within the cytoplasm (partial=1 vs. diffuse=2), so ranging from 0 to 20. Forty-eight consecutive and independent cases of non-small cell lung carcinoma (NSCLC), including two additional cases of PSC, were used as control groups (validation set). Results: No differences in M-VHS were found between biopsies and surgical specimens of PSC, thus confirming the occurrence of stable epithelial mesenchymal transition (EMT) and hence the specific diagnosis of PSC. All types of PSC shared the same M-VHS. The M-VHS of 46 conventional NSCLC was by far lower (p

Original languageEnglish
Pages (from-to)1463-1473
Number of pages11
JournalAnticancer Research
Volume32
Issue number4
Publication statusPublished - Apr 2012

Fingerprint

Vimentin
Carcinoma
Biopsy
Lung
Non-Small Cell Lung Carcinoma
Carcinosarcoma
Epithelial-Mesenchymal Transition
Neoplasms
Cytoplasm
Immunohistochemistry
Control Groups

Keywords

  • Biopsy
  • Cytokeratins
  • Immunohistochemistry
  • Lung cancer
  • Morphology
  • p40
  • p63
  • Pulmonary sarcomatoid carcinoma
  • TTF1
  • Vimentin

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. / Pelosi, Giuseppe; Melotti, Flavia; Cavazza, Alberto; Rossi, Giulio; Maisonneuve, Patrick; Graziano, Paolo; Barbareschi, Mattia; Nakatani, Yukio; Papotti, Mauro.

In: Anticancer Research, Vol. 32, No. 4, 04.2012, p. 1463-1473.

Research output: Contribution to journalArticle

Pelosi, Giuseppe ; Melotti, Flavia ; Cavazza, Alberto ; Rossi, Giulio ; Maisonneuve, Patrick ; Graziano, Paolo ; Barbareschi, Mattia ; Nakatani, Yukio ; Papotti, Mauro. / A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples. In: Anticancer Research. 2012 ; Vol. 32, No. 4. pp. 1463-1473.
@article{62e11e52dd1e46c3a6d44e26f3a092ac,
title = "A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples",
abstract = "Background: As pulmonary sarcomatoid carcinomas (PSCs) are life-threatening tumors, an improvement in their recognition in small-sized tumor samples is clinically warranted. Materials and Methods: Preoperative biopsy samples and paired surgical specimens from 20 pleomorphic carcinomas, two pulmonary blastemas and one carcinosarcoma (training set) were studied for vimentin immunohistochemistry. A modified vimentin histologic score (M-VHS) was devised by multiplying three independently assessed parameters, i.e. the percentage of positive cells (from 0 to 5+, by quintiles), the intensity of immunostaining (low=1 vs. strong=2) and the distribution pattern within the cytoplasm (partial=1 vs. diffuse=2), so ranging from 0 to 20. Forty-eight consecutive and independent cases of non-small cell lung carcinoma (NSCLC), including two additional cases of PSC, were used as control groups (validation set). Results: No differences in M-VHS were found between biopsies and surgical specimens of PSC, thus confirming the occurrence of stable epithelial mesenchymal transition (EMT) and hence the specific diagnosis of PSC. All types of PSC shared the same M-VHS. The M-VHS of 46 conventional NSCLC was by far lower (p",
keywords = "Biopsy, Cytokeratins, Immunohistochemistry, Lung cancer, Morphology, p40, p63, Pulmonary sarcomatoid carcinoma, TTF1, Vimentin",
author = "Giuseppe Pelosi and Flavia Melotti and Alberto Cavazza and Giulio Rossi and Patrick Maisonneuve and Paolo Graziano and Mattia Barbareschi and Yukio Nakatani and Mauro Papotti",
year = "2012",
month = "4",
language = "English",
volume = "32",
pages = "1463--1473",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "4",

}

TY - JOUR

T1 - A modified vimentin histological score helps recognize pulmonary sarcomatoid carcinoma in small biopsy samples

AU - Pelosi, Giuseppe

AU - Melotti, Flavia

AU - Cavazza, Alberto

AU - Rossi, Giulio

AU - Maisonneuve, Patrick

AU - Graziano, Paolo

AU - Barbareschi, Mattia

AU - Nakatani, Yukio

AU - Papotti, Mauro

PY - 2012/4

Y1 - 2012/4

N2 - Background: As pulmonary sarcomatoid carcinomas (PSCs) are life-threatening tumors, an improvement in their recognition in small-sized tumor samples is clinically warranted. Materials and Methods: Preoperative biopsy samples and paired surgical specimens from 20 pleomorphic carcinomas, two pulmonary blastemas and one carcinosarcoma (training set) were studied for vimentin immunohistochemistry. A modified vimentin histologic score (M-VHS) was devised by multiplying three independently assessed parameters, i.e. the percentage of positive cells (from 0 to 5+, by quintiles), the intensity of immunostaining (low=1 vs. strong=2) and the distribution pattern within the cytoplasm (partial=1 vs. diffuse=2), so ranging from 0 to 20. Forty-eight consecutive and independent cases of non-small cell lung carcinoma (NSCLC), including two additional cases of PSC, were used as control groups (validation set). Results: No differences in M-VHS were found between biopsies and surgical specimens of PSC, thus confirming the occurrence of stable epithelial mesenchymal transition (EMT) and hence the specific diagnosis of PSC. All types of PSC shared the same M-VHS. The M-VHS of 46 conventional NSCLC was by far lower (p

AB - Background: As pulmonary sarcomatoid carcinomas (PSCs) are life-threatening tumors, an improvement in their recognition in small-sized tumor samples is clinically warranted. Materials and Methods: Preoperative biopsy samples and paired surgical specimens from 20 pleomorphic carcinomas, two pulmonary blastemas and one carcinosarcoma (training set) were studied for vimentin immunohistochemistry. A modified vimentin histologic score (M-VHS) was devised by multiplying three independently assessed parameters, i.e. the percentage of positive cells (from 0 to 5+, by quintiles), the intensity of immunostaining (low=1 vs. strong=2) and the distribution pattern within the cytoplasm (partial=1 vs. diffuse=2), so ranging from 0 to 20. Forty-eight consecutive and independent cases of non-small cell lung carcinoma (NSCLC), including two additional cases of PSC, were used as control groups (validation set). Results: No differences in M-VHS were found between biopsies and surgical specimens of PSC, thus confirming the occurrence of stable epithelial mesenchymal transition (EMT) and hence the specific diagnosis of PSC. All types of PSC shared the same M-VHS. The M-VHS of 46 conventional NSCLC was by far lower (p

KW - Biopsy

KW - Cytokeratins

KW - Immunohistochemistry

KW - Lung cancer

KW - Morphology

KW - p40

KW - p63

KW - Pulmonary sarcomatoid carcinoma

KW - TTF1

KW - Vimentin

UR - http://www.scopus.com/inward/record.url?scp=84859958042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859958042&partnerID=8YFLogxK

M3 - Article

C2 - 22493387

AN - SCOPUS:84859958042

VL - 32

SP - 1463

EP - 1473

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 4

ER -